Nitin Gadkari says he was not conscious that GoI is already working with 12 corporations to ramp up vaccine manufacturing

While addressing a digital press convention yesterday, Union Minister Nitin Gadkari had advised that extra pharmaceutical corporations ought to be allowed to make the Covid-19 vaccines within the nation to spice up the inoculation drive.
“If the demand of vaccine is more than its supply then it creates a problem. So, instead of one company, 10 more companies should be allowed to make vaccines by paying 10 percent royalty to the original patent holder of the vaccine,” mentioned Gadkari whereas talking at a digital convention organized by Swadesi Jagran Manch.
#WATCH | If vaccine demand is greater than provide it creates drawback. Instead of 1, let 10 extra corporations be given license for vaccine manufacture…Let them provide in nation & later if there’s surplus, they might export. It will be executed in 15-20 days: Union Min Nitin Gadkari (18.05) pic.twitter.com/gVOqMuVRNr— ANI (@ANI) May 19, 2021
However, the Union Minister has now issued a clarification concerning his suggestion stating that he was unaware that the related Ministry has already taken efforts to ramp up the manufacturing to bridge the provision and demand hole.
Gadkari in a sequence of Tweet mentioned, “I was unaware that before my speech Minister for Chemical & Fertilizers Shri @mansukhmandviya had explained government’s efforts to ramp up vaccine production. After conference, he also informed me that, GoI is already facilitating vaccine manufacturing by 12 different plants/companies and rapid ramp up of production is expected in near future as a result of these efforts.”
Yesterday whereas collaborating on the convention organised by Swadeshi Jagaran Manch, I had made a suggestion to ramp up vaccine manufacturing. I used to be unaware that earlier than my speech Minister for Chemical & Fertilizers Shri @mansukhmandviya had defined authorities’s efforts to ramp up— Nitin Gadkari (@nitin_gadkari) May 19, 2021
Congratulating the staff for his or her well timed efforts, Gadkari mentioned that it was essential for him to place the dialogue on file. 
Vaccine availability and procurement
As per the newest press launch by the Ministry of Health and Family Welfare, a complete of 5 crore 86 lakh and 29 thousand doses can be offered freed from value by the Government of India to states/ UTs from May 01, 2021 to June 15, 2021.
Citing data obtained from the vaccine producers, a complete of 4 crore, 87 lakh and 55 thousand doses can be made obtainable until the top of June 2021 for direct procurement by the states/UTs.
Moreover, in an try to supply a significant increase to the vaccination drive, the Government of India’s procurement pipeline means that:
75 crore doses of Covishield55 crore doses of Covaxin30 crore doses of Bio E Sub unit vaccine20 crore doses of SII Novavax 10 crore doses of BB Nasal vaccine06 crore doses of Gennova mRNA vaccine15 crore doses of Sputnik vaccine can be procured between August 2021 to December 2021The Union Health Ministry has been offering advance data on the provision of Covid-19 vaccine doses to be provided to the states/ UTs each fortnight.
Production by Bharat Biotech at Pune plant
The Bombay High Court permitted Biovet Private Limited, an affiliate firm of Bharat Biotech, to take possession of a totally operational and ready-to-use vaccine manufacturing plant in Pune to provide Covaxin, the indigenous vaccine towards Covid-19.
To assist the most important vaccination drive being carried out by India, Bharat Biotech has ramped up the manufacturing capability of Covaxin to 700 million doses each year.
The manufacturing scale-up is going on in a step-wise method throughout a number of amenities with newer ones being added to the checklist.